xinbang phar.(SZ:002390) Jing Ji Guan Cha Wang·2026-02-08 03:54Group 1 - The case of Wang Xiaolin, former Vice President of Guiyang Medical College, involves illegal acceptance of over 150 million yuan in bribes from 2002 to 2023, linked to various medical procurement and project contracts [1] - Wang Xiaolin was sentenced to death with a two-year reprieve, stripped of political rights for life, and ordered to forfeit all personal property due to the severity of his crimes [1] - The court acknowledged mitigating factors such as Wang's confession and the return of most illicit gains, leading to a lighter sentence [1] Group 2 - The corruption case has implicated A-share listed company Xinbang Pharmaceutical, which was founded in 1995 and became the first listed company in Qiannan Prefecture in 2010 [2] - Xinbang Pharmaceutical acquired a 98.25% stake in Keke Pharmaceutical in 2013, which was formed from the drug sales department of the Guiyang Medical College Affiliated Hospital, establishing a connection to Wang Xiaolin [2][3] - Keke Pharmaceutical contributed significantly to Xinbang Pharmaceutical's financials in 2023, accounting for 35.26% of revenue and 34.75% of net assets [3] Group 3 - The corruption chain involved Wang Xiaolin's influence in halting a merger with a state-owned enterprise, leading to Keke Pharmaceutical being acquired by Xinbang Pharmaceutical instead, resulting in substantial bribes exchanged [3] - Legal proceedings against Xinbang Pharmaceutical began in 2025, with the company announcing that the ongoing litigation would not significantly impact its current or future profits, although the exact effects remain uncertain [4][5] - The company has received formal charges from the prosecutor's office regarding the alleged bribery, indicating ongoing legal challenges [5]